Biologic effects of recent antimitotic compounds. A comparative evaluation.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002642:Chick Embryo / Q000187:drug effects*; D003078:Colchicine / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis*; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007962:Leukocytes / Q000378:metabolism*; D008466:Mechlorethamine / Q000494:pharmacology*; D008558:Melphalan / Q000494:pharmacology*; D008938:Mitosis / Q000187:drug effects*; D011239:Prednisolone / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis*; D014228:Triaziquone / Q000494:pharmacology*; D014747:Vinblastine / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology*
D000970:Antineoplastic Agents; D006834:Hydrazines; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D012313:RNA; D003520:Cyclophosphamide; D004247:DNA; D011239:Prednisolone; D014228:Triaziquone; D008558:Melphalan; D003078:Colchicine; D005472:Fluorouracil